References in periodicals archive ?
001 ASCD: atherosclerotic cardiac disease; CK-MB: creatine kinase-MB fraction; DM: diabetes mellitus; NGAL: neutrophil gelatinase associated lipocalin; PTX-3: pentraxin3; Tn-I: troponinI [alpha] Described by number (n) and percentage (%) [beta] Described by median value (minimum-maximum values) Table 3.
Urinary Neutrophil Gelatinase Associated Lipocalin (NGAL) for Early Diagnosis of Acute Kidney Injury in Renal Transplant Recipients.
Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase.
NGAL is a polypeptide chain of 178 amino acids that has a small size of 25-kDa and covalently bonds to neutrophil gelatinase.
The use of plasma and urine neutrophil gelatinase associated lipocalin (NGAL) and Cystatin C in early diagnosis of septic acute kidney injury in critically ill patients.
Neutrophil gelatinase associated lipocalin: a novel biomarker for the early diagnosis of acute kidney injury in the emergency department.
These remain our renal biomarkers of choice until the use of newer renal biomarkers, such as neutrophil gelatinase associated lipocalin and cystatin C, becomes commonplace.
Neutrophil gelatinase associated lipocalin (NGAL) is a new early marker for acute kidney injury.
The report analyses the market size and volume of key biomarkers such as Serum Creatinine (SCr) and Neutrophil Gelatinase Associated Lipocalin (NGAL) in Germany.
3 March 2014 - Danish biotech group Bioporto A/S (CPH:BIOPOR) said Monday it had settled a patent lawsuit with Swedish peer Phadia, regarding the use of human neutrophil lipocalin (HNL), another name for the protein neutrophil gelatinase associated lipocalin (NGAL), as a diagnostic marker for human diseases.
8 March 2011 - Danish biotech company Bioporto A/S (CPH: BIOPOR) said today it has licensed its neutrophil gelatinase associated lipocalin (NGAL) patents to US diagnostic instruments maker Instrumentation Laboratory Co.

Full browser ?